Yu-chen Zhang
State Key Laboratory Of Oncology In South China, P.R. China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Serum triglyceride and apolipoprotein A1 as dynamic biomarkers in extranodal NK/T-cell lymphoma (ENKTL): A multicenter retrospective and prospective validation study.
Journal: Annals of hematology
Published: July 21, 2025
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: October 27, 2023
Novel target and treatment agents for natural killer/T-cell lymphoma.
Journal: Journal of hematology & oncology
Published: June 20, 2023
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma.
Journal: Cell reports. Medicine
Published: April 07, 2022
Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphoma.
Journal: British journal of haematology
Published: June 27, 2021
A prognostic immune risk score for diffuse large B-cell lymphoma.
Journal: British journal of haematology
Published: December 22, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026